NCT04626024 2025-12-19
TOKIN
Baylor College of Medicine
Phase 2 Recruiting
Clinical Trials
8 trialsNCT03831776 2025-06-08
BosuPeg
St. Olavs Hospital
Phase 2 Completed
NCT02269267 2023-03-03
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
Medical College of Wisconsin
Phase 2 Completed
NCT02810990 2023-02-03
BEST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
NCT02638467 2020-11-05
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
University of Milano Bicocca
Phase 2 Completed
NCT02906696 2020-05-11
Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03205267 2017-07-02
BODO
University of Bonn
Phase 2 Unknown
NCT01331291 2016-07-25
Bosutinib in Adult Patients With Recurrent Glioblastoma
Massachusetts General Hospital
Phase 2 Completed